Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro

被引：0

作者：

Hong Liu

Guonan Zhang

Jianming Huang

Shiqi Ma

Kun Mi

Jia Cheng

Yi Zhu

Xiao Zha

Wei Huang

机构：

[1] West China Second University Hospital of Sichuan University,Department of Obstetrics and Gynecology

[2] Sichuan Cancer Hospital,Department of Gynecologic Oncology

[3] Sichuan Cancer Institute,Department of Biochemistry and Molecular Biology

[4] Sichuan Cancer Hospital,Department of Ultrasound

来源：

Journal of Translational Medicine | / 14卷

关键词：

Epithelial ovarian cancer; TLR4/MD-2 complex; MyD88/NF-κB signaling; Atractylenolide I; Immunosuppressive cytokines; Indoleamine 2,3-dioxygenase;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 319 条

[1]

Siegel RL(2015)Cancer statistics, 2015 CA Cancer J Clin 65 5-29

[2]

Miller KD(2014)Ovarian cancer biology and immunotherapy Int Rev Immunol 33 428-440

[3]

Jemal A(2013)Cabillic F Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer J Transl Med 11 147-372

[4]

Latha TS(2010)Ovarian cancer creates a suppressive microenvironment to escape immune elimination Gynecol Oncol 117 366-233

[5]

Panati K(2008)Cancers take their toll-the function and regulation of toll-like receptors in cancer cells Oncogene 27 225-224

[6]

Gowd DS(2008)TLR signaling by tumor and immune cells: a double-edged sword Oncogene 27 218-5014

[7]

Reddy MC(2005)Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Res 65 5009-1385

[8]

Lomada D(2009)Toll-like receptor expression in normal ovary and ovarian tumors Cancer Immunol Immunother 58 1375-1195

[9]

Lavoué V(2014)Toll-like receptor-4 modulation for cancer immunotherapy Front Immunol 5 328-558

[10]

Thédrez A(2014)The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer PLoS One 9 e100816-1782